Management of recurrent gastrointestinal cancer with ripretinib and surgery
Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine ...
Nov 6, 2023
0
0